Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Otsuka Pharmaceutical Dev. & Commercialization

Division of Otsuka Holdings Co. Ltd./Otsuka Pharmaceutical Co. Ltd.
www.otsuka.com/OPDC

Latest From Otsuka Pharmaceutical Dev. & Commercialization

Will US FDA Remove Higher Strength Opioids From The Market?

Advisory committee members are divided on whether agency should restrict access to higher dose opioids, but most want option kept on the table.

Advisory Committees FDA

Appointments: Amgen, Sirnaomics, Pandion, Purdue, Cardurion, OncoSec Make Senior Hires

Senior executives are to depart Gilead Sciences, Bristol-Myers Squibb and Amgen, while C-suite and board hires have been reported at Sirnaomics, Pandion, Purdue Pharma, Cardurion and OncoSec.

Appointments Commercial

R&D Successes Celebrated At 2018 CARE Awards

Informa Pharma Intelligence pays tribute to the people driving the advances in drug development and their commitments to advancing human health with the third annual CARE Awards.

BioPharmaceutical Research & Development

R&D Successes Celebrated At 2018 CARE Awards

Informa Pharma Intelligence pays tribute to the people driving the advances in drug development and their commitments to advancing human health with the third annual CARE Awards.

BioPharmaceutical Research & Development
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register